Streetbeat News

Stock Prices

ATHA

Athira Pharma's stock is rising following the announcement that it will present results from its Phase 2/3 LIFT-AD clinical trial for Fosgonimeton, a treatment for Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 7:37 pm

CARR

Carrier Global Inc. (NYSE:CARR) has seen a slight drop in stock price, but a significant increase over the past year. Its P/E ratio is lower than the industry average, suggesting potential undervaluation or low growth expectations. Investors should consider multiple metrics for a comprehensive analysis.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 7:31 pm

PAA

Plains All American Inc. (NASDAQ:PAA) is trading at $17.05, with a recent decrease of 0.35%. Over the past month, the stock decreased by 5.40%, but increased by 10.29% over the past year. The company's P/E ratio of 15.41 is lower than the industry average of 16.37, suggesting potential undervaluation or weak growth prospects.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 7:30 pm

DHR

Danaher Corp (NYSE:DHR) reported Q3 sales of $5.79 billion, surpassing expectations. Despite a positive bioprocessing order growth, the company forecasts a slight decline in 2024 core revenue. Analysts maintain their ratings, with William Blair keeping an Outperform rating and Goldman Sachs a Neutral rating with a $250 price target. DHR stock fell 4.01% to $261.18.

Portfolio Pulse from Vandana Singh

October 22, 2024 | 7:28 pm

NFLX

Netflix Inc (NASDAQ:NFLX) shares have surged 9% to a new 52-week high following impressive Q3 results, including a 15% revenue increase and 14.4% growth in global streaming memberships. The company also closed its Southern California game studio, signaling a shift in gaming strategy. Netflix projects strong Q4 revenue and EPS growth, with promising ad-supported model performance and exciting content lineup.

Portfolio Pulse from Henry Khederian

October 22, 2024 | 7:24 pm

BSGM

BioSig Technologies' common stock will resume trading on the NASDAQ Capital Market Exchange on October 23, 2024, after a successful appeal granted an extension until March 7, 2025, to meet the Market Value of Listed Securities requirement.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 7:17 pm

GPC

IRTC

LOGI

MLI

PII

SGMO

VZ

U.S. stocks showed mixed performance with the Nasdaq Composite gaining 0.2%. Verizon shares fell 5% after Q3 results missed sales estimates. iRhythm Technologies surged 22% on FDA clearance news, while Mueller Industries rose 16% on strong sales. Sangamo Therapeutics gained 37% after FDA approval for an accelerated pathway. Genuine Parts and Polaris shares dropped due to disappointing earnings.

Portfolio Pulse from Avi Kapoor

October 22, 2024 | 7:16 pm

GM

General Motors (NYSE:GM) is experiencing a stock breakout following positive earnings, surpassing a key resistance level at $50. This indicates a potential new uptrend as demand outpaces supply, forcing buyers to bid higher prices.

Portfolio Pulse from Mark Putrino

October 22, 2024 | 7:15 pm

ADMA

ADMA Biologics (NYSE:ADMA) has seen a 37.52% increase in its short percent of float, now at 7.55%. This indicates a rise in bearish sentiment, although it remains below the peer group average of 15.05%. Short interest can signal market sentiment and potential price movements.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 7:15 pm

SITE

SiteOne Landscape Supply (NYSE:SITE) has seen a 9.2% decrease in its short percent of float, now at 5.82%. This is higher than its peers' average of 4.25%. It would take traders 9.87 days to cover short positions. A decrease in short interest can indicate a more bullish sentiment.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 7:15 pm